PubMed

Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.

Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM.

Ann Intern Med. 2005 May 17;142(10):821-31.PMID: 15897532 [PubMed - indexed for MEDLINE]Related articlesFree article

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.

Veenstra DL, Sullivan SD, Clarke L, Iloeje UH, Tafesse E, Di Bisceglie A, Kowdley KV, Gish RG.

Pharmacoeconomics. 2007;25(11):963-77.PMID: 17960954 [PubMed - indexed for MEDLINE]Related articles

Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis.

Kanwal F, Farid M, Martin P, Chen G, Gralnek IM, Dulai GS, Spiegel BM.

Am J Gastroenterol. 2006 Sep;101(9):2076-89.PMID: 16968510 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Antiviral regimens for chronic hepatitis B virus infection.

[No authors listed]

Ann Intern Med. 2005 May 17;142(10):I39. No abstract available. PMID: 15897528 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.

Yuan Y, Iloeje UH, Hay J, Saab S.

J Manag Care Pharm. 2008 Jan-Feb;14(1):21-33.PMID: 18240879 [PubMed - indexed for MEDLINE]Related articlesFree article

A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B.

Takeda A, Jones J, Shepherd J, Davidson P, Price A.

J Viral Hepat. 2007 Feb;14(2):75-88. Review.PMID: 17244247 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore.

Lacey LF, Gane E.

J Viral Hepat. 2007 Nov;14(11):751-66.PMID: 17927611 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B.

Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R.

Aliment Pharmacol Ther. 2006 Feb 1;23(3):409-19.PMID: 16423000 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis.

Veenstra DL, Spackman DE, Di Bisceglie A, Kowdley KV, Gish RG.

Aliment Pharmacol Ther. 2008 Jun;27(12):1240-52. Epub 2008 Mar 27. Review. Erratum in: Aliment Pharmacol Ther.2008 Jul;28(1): 166. Bisceglie, A [corrected to Di Bisceglie, A]. PMID: 18373637 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation.

Jones J, Shepherd J, Baxter L, Gospodarevskaya E, Hartwell D, Harris P, Price A.

Health Technol Assess. 2009 Jul;13(35):1-172, iii. Review.PMID: 19607759 [PubMed - indexed for MEDLINE]Related articlesFree article

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.

Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, Mecenate F, Paffetti A, Barlattani A, Struglia C, Villani R, Nauri L, Nosotti L, Armignacco O, Ferri F, Camporiondo MP, Soccorsi F; Club Epatologi Ospedalieri (CLEO) Group.

Clin Ther. 2008 Feb;30(2):317-23.PMID: 18343270 [PubMed - indexed for MEDLINE]Related articles

Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: a systematic review of economic evidence.

Sun X, Qin WX, Li YP, Jiang XH.

J Gastroenterol Hepatol. 2007 Sep;22(9):1369-77. Review.PMID: 17716343 [PubMed - indexed for MEDLINE]Related articles

Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.

Saab S, Ham MY, Stone MA, Holt C, Tong M.

Liver Transpl. 2009 Apr;15(4):413-20.PMID: 19326401 [PubMed - indexed for MEDLINE]Related articles

HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan.

Veenstra DL, Sullivan SD, Lai MY, Lee CM, Tsai CM, Patel KK.

Value Health. 2008 Mar-Apr;11(2):131-8.PMID: 18380625 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.

Veenstra DL, Sullivan SD, Dusheiko GM, Jacobs M, Aledort JE, Lewis G, Patel KK.

Eur J Gastroenterol Hepatol. 2007 Aug;19(8):631-8.PMID: 17625431 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

Peters MG, Hann Hw H, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df D, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL.

Gastroenterology. 2004 Jan;126(1):91-101.PMID: 14699491 [PubMed - indexed for MEDLINE]Related articles

Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

Dienstag JL, Wei LJ, Xu D, Kreter B.

Clin Drug Investig. 2007;27(1):35-49. Review.PMID: 17177578 [PubMed - indexed for MEDLINE]Related articles

Economic evaluation of chronic hepatitis B treatments in Taiwan.

Lacey L, Chien RN, Chuang WL, Pwu RF.

J Gastroenterol Hepatol. 2008 Apr;23(4):571-9.PMID: 18397486 [PubMed - indexed for MEDLINE]Related articles

[Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea]

Kim BK, Kwon SY, Lee CH, Choe WH, Choi HM, Koo HW.

Korean J Hepatol. 2009 Mar;15(1):25-41. Korean. PMID: 19346783 [PubMed - indexed for MEDLINE]Related articlesFree article